Teleflex (TFX) has agreed to sell its acute care, interventional urology and OEM businesses to two buyers for a combined $2.03 billion in cash, subject to adjustments. Intersurgical will acquire the ...

Teleflex is selling its acute care, interventional urology, and original equipment manufacturer (OEM) businesses in two separate deals totalling over $2bn as part of the company’s broader portfolio ...

Shares of medical technology company Teleflex (NYSE:TFX) jumped 11.1% in the afternoon session after the company announced it agreed to sell its Acute Care, Interventional Urology, and OEM businesses ...

Private equity firms Montagu and Kohlberg have announced plans to acquire Wayne, PA-based OEM Teleflex Medical for $1.5 billion in a carve-out transaction. Teleflex Medical OEM, which has been in ...

After announcing plans to split up the company near the top of this year, Teleflex said it has found new homes for its businesses spanning acute care, urology and medical hardware manufacturing. Two ...

Teleflex Medical OEM has seven state-of-the-art facilities across the US, Mexico, and Ireland Greg Stotts, who joined Teleflex in 2006 and currently serves as Teleflex Medical OEM’s president and ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Dec 9 (Reuters) - Medical device maker Teleflex (TFX.N), opens new tab said on Tuesday it would sell three units for a combined $2.03 billion, as it sharpens its focus on its critical care and ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Founded in 1943, the company has ...

Teleflex Inc. announced that it has entered into definitive agreements to sell its OEM business as well as its acute care and interventional urology divisions to two different buyers. Intersurgical ...

WAYNE, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced it has entered into definitive agreements to sell the ...

Teleflex’s TFX Interventional Urology portfolio is well positioned for sustained growth, led by UroLift’s expanding global footprint and strong clinical differentiation. Supported by favorable ...